Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update.

ABSTRACT: Dystonia, typically characterized by slow repetitive involuntary movements, stiff abnormal postures, and hypertonia, is common among individuals with cerebral palsy (CP). Dystonia can interfere with activities and have considerable impact on motor function, pain/comfort, and ease of caregiving. Although pharmacological and neurosurgical approaches are used clinically in individuals with CP and dystonia that is causing interference, evidence to support these options is limited. This clinical practice guideline update comprises 10 evidence-based recommendations on the use of pharmacological and neurosurgical interventions for individuals with CP and dystonia causing interference, developed by an international expert panel following the Grading of Recommendations, Assessment, Development and

SUBMITTER: Fehlings D 

PROVIDER: S-EPMC11579811 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature